Skip to content

The Clinical Efficacy of patients with chronic insomnia (liver depression spleen deficiency) Treated by Herb-partitioned moxibustion on the navel

The Clinical Efficacy of patients with chronic insomnia (liver depression spleen deficiency) Treated by Herb-partitioned moxibustion on the navel

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005574
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic insomnia

Interventions

experiment group:Herb-partitioned moxibustion on the navel
control group:starch-partitioned moxibustion on the navel

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 60 years (no gender limitation); 2.Comply with the diagnostic criteria for chronic insomnia in ICSD-3; 3.Comply with the diagnostic criteria for chronic insomnia in troditional Chinese Medicine and syndrome differentiation belongs to liver depression spleen deficiency; 4.Pittsburgh Sleep Therapy Index (PSQI)>5 points; 5.Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Serious heart,lung, liver, kidney and other systemic diseases; or migraine, dysmenorrhea and other chronic painful diseases; infectious diseases; 2.Extremely severe depression(patient health questionnaire, PHQ-9=20) and other mental disorders 3.Other sleep disorders rather than chronic insomniasuch as sleep apnea,restless leg syndrome; 4.Pregnant or breastfeeding or having the plan to be pregnant; 5.Patients not suitable for moxibustion, such as: allergic constitution,severe dermatosis around the acupoints; 6.Patients who had participated in or were participating in other clinical trials within 3 months prior to enrollment; 7.Patients with a history of alcohol abuse or drug dependence 8.Patients with joint deformity, difficulty in inactivity and unable to lie supine for a long time.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index;Pittsburgh Sleep Quality Index;fatigue scale-14;generalized anxiety disorder-7;Actigraphy;Epworth Sleepiness Scale;patient health questionnaire;

Countries

China

Contacts

Public ContactYunfei Chen
icyf1968@163.com18930568221

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026